REVOLUTION MEDICINES INC RVMDW
*W EXP 12/17/202 · Equity WRT · CUSIP 76155X118
Company in Redwood City, United States
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersRedwood City, CA
- Founded2014
- Websiterevmed.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($95 this quarter). Holder counts are more reliable. Implied quarter-end price ≈ $0.27. Options: 1 managers hold calls ($22.8k notional), 0 hold puts (—).
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2023 | 23 |
| Q1 2024 | 25 |
| Q2 2024 | 26 |
| Q3 2024 | 26 |
| Q4 2024 | 25 |
| Q1 2025 | 25 |
| Q2 2025 | 24 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2024 | 4 | 5 |
| Q2 2024 | 4 | 5 |
| Q3 2024 | 2 | 3 |
| Q4 2024 | 6 | 5 |
| Q1 2025 | 6 | 5 |
| Q2 2025 | 4 | 5 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2024 | $22.3m | $0 | 0.00 |
| Q4 2024 | $12.3m | $0 | 0.00 |
| Q1 2025 | $3.3k | $0 | 0.00 |
| Q2 2025 | $22.8k | $0 | 0.00 |
Biggest buyers
| Lunate Capital Ltd | New | +450.0k |
| DLK Investment Management, LLC | Added | +87.5k |
| LMR Partners LLP | Added | +39.3k |
| ROYAL BANK OF CANADA | Added | +200 |
Biggest sellers
| Walleye Capital LLC | Sold out | -175.8k |
| CSS LLC/IL | Reduced | -15.5k |
| ARISTEIA CAPITAL, L.L.C. | Reduced | -6.1k |
| TORONTO DOMINION BANK | Reduced | -300 |
| CLEAR STREET LLC | Sold out | -100 |
Biggest calls
| MILLENNIUM MANAGEMENT LLC | Unchanged | $22.8k86.8k shares |
Biggest puts
| None |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2023 | 0 | — | 6 | $4.9m | $2.6m |
| Q4 2023 | 0 | — | 5 | $3.0m | $3.0m |
| Q1 2024 | 0 | — | 5 | $1.8m | $1.8m |
| Q2 2024 | 0 | — | 7 | $3.3m | $3.1m |
| Q3 2024 | 0 | — | 6 | $5.5m | $5.5m |
| Q4 2024 | 1 | $60.0m | 7 | $13.1m | $13.1m |
| Q1 2025 | 0 | — | 5 | $1.0m | $1.0m |
| Q2 2025 | 0 | — | 6 | $1.7m | $1.7m |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-06-20 | Cislini Jeff General Counsel | Sold plan | $75.7k1.9k shares |
| 2025-06-16 | Horn Margaret A Chief Operating Officer | Sold plan | $558.1k3.6k shares |
| 2025-06-16 | GOLDSMITH MARK A Officer, director | Sold plan | $537.5k13.5k shares |
| 2025-06-16 | Kelsey Stephen Michael Officer | Sold plan | $170.8k4.3k shares |
| 2025-06-16 | Horn Margaret A Chief Operating Officer | Sold plan | $139.8k3.5k shares |
| 2025-06-16 | Wei Lin Chief Medical Officer | Sold plan | $86.6k2.2k shares |
| 2025-06-16 | Anders Jack Chief Financial Officer | Sold plan | $86.4k2.2k shares |
| 2025-06-16 | Cislini Jeff General Counsel | Sold plan | $74.8k1.9k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| LMR Partners LLP 0.01% of their portfolio | 2.6m $695.1k | Added +39.3k |
| D. E. Shaw & Co., Inc. 0.00% of their portfolio | 1.5m $392.8k | Unchanged |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 599.3k $162.0k | Unchanged |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.00% of their portfolio | 500.0k $131.3k | Unchanged |
| Lunate Capital Ltd 0.07% of their portfolio | 450.0k $118.2k | New |
| SOROS CAPITAL MANAGEMENT LLC 0.03% of their portfolio | 364.8k $95.8k | Unchanged |
| ARISTEIA CAPITAL, L.L.C. 0.00% of their portfolio | 313.0k $73.5k | Reduced -6.1k |
| PERCEPTIVE ADVISORS LLC 0.00% of their portfolio | 250.0k $65.7k | Unchanged |
| TORONTO DOMINION BANK 0.00% of their portfolio | 221.4k $58.2k | Reduced -300 |
| Bleichroeder LP 0.01% of their portfolio | 200.0k $52.5k | Unchanged |
| Sculptor Capital LP 0.00% of their portfolio | 178.1k $41.8k | Unchanged |
| DLK Investment Management, LLC 0.02% of their portfolio | 164.5k $43.2k | Added +87.5k |
| Davidson Kempner Capital Management LP 0.00% of their portfolio | 150.0k $39.4k | Unchanged |
| Driehaus Capital Management LLC 0.00% of their portfolio | 135.0k $36.2k | Unchanged |
| FARALLON CAPITAL MANAGEMENT, L.L.C. 0.00% of their portfolio | 120.1k $32.4k | Unchanged |
| CANTOR FITZGERALD, L. P. 0.00% of their portfolio | 109.6k $28.8k | Unchanged |
| Weiss Asset Management LP 0.00% of their portfolio | 73.6k $19.9k | Unchanged |
| WOLVERINE ASSET MANAGEMENT LLC 0.00% of their portfolio | 70.3k $18.5k | Unchanged |
| TD Asset Management Inc 0.00% of their portfolio | 40.6k $11.0k | Unchanged |
| CSS LLC/IL 0.01% of their portfolio | 35.8k $84.7k | Reduced -15.5k |
| TD Waterhouse Canada Inc. 0.00% of their portfolio | 448 $95 | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 400 $0 | Added +200 |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 64 $17 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |